Document is current
Any future updates will be listed below
-
Authors
Li, Jin https://orcid.org/0000-0001-8975-6776
Wang, Jun
Ibarra, Ignacio L.
Cheng, Xuesen https://orcid.org/0000-0002-0678-4411
Luecken, Malte D. https://orcid.org/0000-0001-7464-7921
Lu, Jiaxiong https://orcid.org/0009-0003-4835-174X
Monavarfeshani, Aboozar
Yan, Wenjun https://orcid.org/0000-0003-3568-4265
Zheng, Yiqiao https://orcid.org/0000-0003-4133-0439
Zuo, Zhen
Colborn, Samantha Lynn Zayas
Cortez, Berenice Sarahi
Owen, Leah A. https://orcid.org/0000-0003-3802-3868
Wick, Brittney
Bao, Xuan
Haeussler, Maximilian
Tran, Nicholas M.
Shekhar, Karthik
Sanes, Joshua R. https://orcid.org/0000-0001-8926-8836
Stout, J. Timothy
Chen, Shiming
Li, Yumei
DeAngelis, Margaret M. https://orcid.org/0000-0003-3731-142X
Theis, Fabian J. https://orcid.org/0000-0002-2419-1943
Chen, Rui https://orcid.org/0000-0002-4387-9735
- License Information
-
More Information
Article History
Received: 20 October 2023
Accepted: 19 November 2025
First Online: 23 January 2026
Competing interests
: F.J.T. consults for Immunai, CytoReason, Cellarity and Omniscope, and owns interests in Dermagnostix GmbH and Cellarity. M.D.L. has received research contracts from the CZI and speaker fees from Pfizer and Janssen Pharmaceuticals. The other authors declare no competing interests.
